Determining carotid plaque vulnerability using ultrasound center frequency shifts

Tobias Erlöv1, Magnus Cinthio1, Andreas Edsfeldt2

  • 1Department of Biomedical Engineering, Faculty of Engineering, Lund University, Sweden.

Atherosclerosis
|January 30, 2016
PubMed

Insights

A new ultrasound method accurately identifies vulnerable atherosclerotic plaques by analyzing center frequency shift (CFS). This non-invasive technique aids in detecting high-risk carotid plaques, improving cardiovascular disease risk assessment.

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Ultrasound
  • Atherosclerosis Research

Background:

  • Atherosclerotic cardiovascular disease is a major global health burden, often stemming from vulnerable plaque rupture.
  • Current non-invasive methods for identifying high-risk plaques remain suboptimal.
  • Accurate detection of vulnerable plaques is crucial for preventing cardiovascular events like stroke and myocardial infarction.

Purpose of the Study:

  • To validate a novel non-invasive ultrasound technique for identifying high-risk carotid plaques.
  • To assess the capability of center frequency shift (CFS) in characterizing plaque components related to vulnerability.

Main Methods:

  • A new ultrasound method analyzing center frequency shift (CFS) in carotid plaques was evaluated.
  • The method was tested ex vivo on plaque sections and in vivo on patients prior to plaque removal.
  • Ultrasound data were correlated with histological findings of plaque components.

Main Results:

  • CFS demonstrated a significant correlation with a histological plaque vulnerability index (r = -0.726, P = 1.7 × 10(-8)).
  • Plaques with lower CFS exhibited characteristics of rupture-prone lesions, including larger lipid cores and more macrophages.
  • The method achieved 78% accuracy in detecting highly vulnerable plaques, with 77% sensitivity and 78% specificity.

Conclusions:

  • This study introduces the first ultrasound method utilizing CFS to characterize atherosclerotic plaque components influencing vulnerability.
  • The validated non-invasive technique shows promise for improved identification of high-risk carotid plaques.
  • This advancement could lead to better risk stratification and personalized treatment strategies for patients with atherosclerotic disease.
Abstract